Erasca Shares Slip After $500M Stock Offering Is Announced Despite Encouraging Early Data
Erasca Inc. shares fell 3.1% in after-hours trading after the clinical-stage oncology firm unveiled a proposed $500 million underwritten offering of common stock, with underwriters granted a 30-day option for an additional $75 million. The company said proceeds would support R&D and working capital. The financing announcement came the same day Eras…